Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/3/2025

Heart Failure Diagnosis and Cardiac Function Assessment

Diagnostic Criteria and Exclusion Thresholds

  • BNP >100 pg/mL is required to suggest chronic heart failure is likely 1, 2

  • The European Society of Cardiology guidelines state that BNP <100 pg/mL makes chronic heart failure "unlikely" 1, 2

  • For acute presentations, the lower exclusion threshold is 100 pg/mL for BNP 3

  • A normal BNP level combined with a completely normal ECG makes heart failure, especially with systolic dysfunction, unlikely (<10% probability) 1, 2

ECG Findings in Heart Failure Assessment

  • If the ECG is completely normal, heart failure—particularly with systolic dysfunction—is unlikely (<10% probability) 1, 2

  • Normal ECG combined with preserved ejection fraction essentially excludes reduced ejection fraction heart failure 1, 2

Ejection Fraction Classification

  • Ejection fraction of 55-60% is normal and indicates preserved systolic function 4, 5

  • Heart failure with reduced ejection fraction (HFrEF) is defined as EF ≤40% 4, 6

  • EF ≥50% defines HF with preserved EF if HF were present 4, 5

Clinical Reassessment Indicators

  • New symptoms such as progressive shortness of breath, leg swelling, orthopnea (difficulty breathing when lying flat), or paroxysmal nocturnal dyspnea warrant reassessment 4, 5

  • In patients with unexplained exertional dyspnea despite normal resting tests, exercise testing or stress echocardiography might reveal elevated filling pressures with exertion that aren't apparent at rest 4, 5

  • The 2022 ACC/AHA guidelines note that HF with preserved EF can be challenging to diagnose and may require evidence of elevated filling pressures during provocation (exercise, fluid challenge) 4

Heart Failure Staging

  • Stage B heart failure (pre-heart failure) is defined as having structural changes but no symptoms or clinical HF 4

  • Stage B patients have risk factors and structural abnormalities but do not have active heart failure and do not require HF-specific medications 4

  • Focus should be on managing cardiovascular risk factors (hypertension, diabetes, cholesterol) to prevent progression in Stage B patients 4

REFERENCES

6

Wearable Cardiac Vest for HFrEF: EF Thresholds [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025